Schroder Investment Management Group
AUTL

Schroder Investment Management Group’s Autolus Therapeutics AUTL Stock Holding History

Schroder Investment Management Group’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Sell
7,833,282
-1,656,063
-17% -$2.6M 0.01% 625
2026
Q1 		$12.1M Hold
9,489,345
– – 0.01% 618
2025
Q4 		$18.7M Buy
9,489,345
+1,056,092
+13% +$1.62M 0.01% 525
2025
Q3 		$13.4M Buy
8,433,253
+4,824,763
+134% +$9.43M 0.01% 607
2025
Q2 		$8.23M Hold
3,608,490
– – 0.01% 673
2025
Q1 		$5.99M Buy
3,608,490
+743,858
+26% +$1.51M 0.01% 728
2024
Q4 		$6.33M Hold
2,864,632
– – 0.01% 732
2024
Q3 		$10.4M Buy
2,864,632
+412,592
+17% +$1.65M 0.01% 652
2024
Q2 		$8.53M Buy
2,452,040
+779,308
+47% +$3.36M 0.01% 663
2024
Q1 		$10.7M Hold
1,672,732
– – 0.01% 639
2023
Q4 		$10.8M Hold
1,672,732
– – 0.01% 616
2023
Q3 		$3.9M Hold
1,672,732
– – 0.01% 800
2023
Q2 		$3.98M Hold
1,672,732
– – 0.01% 828
2023
Q1 		$3.08M Hold
1,672,732
– – ﹤0.01% 872
2022
Q4 		$3.18M Hold
1,672,732
– – 0.01% 865
2022
Q3 		$3.58M Hold
1,672,732
– – 0.01% 840
2022
Q2 		$4.73M Hold
1,672,732
– – 0.01% 802
2022
Q1 		$7.08M Hold
1,672,732
– – 0.01% 755
2021
Q4 		$8.68M Hold
1,672,732
– – 0.01% 635
2021
Q3 		$11M Hold
1,672,732
– – 0.02% 612
2021
Q2 		$11.1M Hold
1,672,732
– – 0.01% 644
2021
Q1 		$9.59M Hold
1,672,732
– – 0.01% 676
2020
Q4 		$15M Buy
1,672,732
+107,082
+7% +$1.14M 0.02% 551
2020
Q3 		$17.4M Sell
1,565,650
-220,204
-12% -$3.19M 0.03% 463
2020
Q2 		$28.6M Sell
1,785,854
-309,273
-15% -$3.43M 0.05% 339
2020
Q1 		$13.3M Hold
2,095,127
– – 0.03% 472
2019
Q4 		$27.7M Buy
+2,095,127
New +$27.4M 0.05% 424

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Schroder Investment Management Group's AUTL Position: Q2 2026 in Review

Schroder Investment Management Group reduced its Autolus Therapeutics (AUTL) stake by 17% in Q2 2026, selling an estimated $2.6M and leaving 7,833,282 shares worth $12.9M. The position accounts for 0.01% of the portfolio, ranked #625.

Schroder Investment Management Group first reported a position in AUTL in Q4 2019 and has held it in 27 quarters since. The position peaked at $28.6M in Q2 2020. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • Schroder Investment Management Group held 7,833,282 shares of Autolus Therapeutics worth $12.9M as of Q2 2026.
  • Schroder Investment Management Group sold 1,656,063 Autolus Therapeutics shares in Q2 2026, an estimated $2.6M.
  • Autolus Therapeutics made up 0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #625 holding.
  • Schroder Investment Management Group first reported a position in Autolus Therapeutics in Q4 2019 and has held it in 27 quarters since.
  • Schroder Investment Management Group's Autolus Therapeutics position peaked at $28.6M in Q2 2020.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.